Key result
Open fenestration in Fontan patients shows no independent link to adverse outcomes after CMR adjustment.
Why the study?
The long-term effect of open fenestration in Fontan patients is unclear, leading to wide practice variation in fenestration creation and closure.
Does open fenestration affect the composite outcome of death, transplant, plastic bronchitis, or protein-losing enteropathy in post-Fontan patients?
Cohort (n=2,923)
Does open fenestration affect the composite outcome of death, transplant, plastic bronchitis, or protein-losing enteropathy in post-Fontan patients?
Hazard Ratio: 1.7 (95% CI 1.09–2.64)
p-value: p=0.02
In post-Fontan patients, open fenestration is associated with adverse clinical outcomes when adjusting for clinical variables, but this association is attenuated by CMR variables such as ventricular volume.
Open fenestration's association with adverse post-Fontan outcomes attenuates after CMR adjustment; leaves open whether it independently predicts events.
Background The long-term effect of open fenestration in Fontan patients is unclear, leading to wide practice variation of fenestration creation and closure. We evaluated the long-term outcomes of the fenestration using data from the F ontan O utcome R egistry using C ardiac magnetic resonance E xaminations (FORCE) study. Methods Patients were categorized by fenestration status determined by post-Fontan cardiac magnetic resonance imaging (CMR) as open fenestration, non-fenestrated Fontan, spontaneous closure, and device closure. The primary outcome was the time from the CMR to the earliest event of death, listing or receiving a heart transplant, plastic bronchitis, or protein-losing enteropathy. The association between fenestration status and the outcome measure was evaluated using Cox proportional hazard models, adjusted for patients’ clinical and CMR characteristics. Results The cohort consisted of 2,923 patients with a median age at CMR of 14.3 years. Patients with open fenestration were younger and less likely to have a systemic left ventricle. Non-fenestrated Fontan patients were more likely to have a systemic left ventricle and lower indexed single ventricle end-diastolic volume (SVEDVi). An open fenestration was associated with adverse outcomes adjusted for clinical variables (hazard ratio 1.70, 95% CI [1.09, 2.64], p=0.02). The association was no longer significant when adjusted for CMR variables, while every 10ml/m 2 increase in SVEDVi was associated with a 5% increase in the hazard of clinical outcomes (p<0.0001). Conclusions Open fenestration is associated with adverse outcomes when adjusted for clinical characteristics. The association disappeared when additionally adjusting for CMR variables. The current practice of fenestration closure in selected patients leads to comparable outcomes with spontaneous closure and non-fenestrated Fontan.
No takes yet. Share an insight, caveat, or question.
Schiff et al. (2025) conducted a cohort in Fontan patients (n=2,923). Open fenestration vs. Non-fenestrated Fontan, spontaneous closure, and device closure was evaluated on Time from the CMR to the earliest event of death, listing or receiving a heart transplant, plastic bronchitis, or protein-losing enteropathy (HR 1.70, 95% CI 1.09-2.64, p=0.02). Open fenestration in Fontan patients was associated with adverse clinical outcomes (HR 1.70; 95% CI 1.09-2.64; p=0.02), but this association disappeared after adjusting for CMR variables.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: